474 completed, 146 terminated, 135 recruiting, 93 unknown. 984 Phase 2, 276 Phase 1, 47 Phase 3.
Follow Precursor Cell Lymphoblastic Leukemia-Lymphoma: new trials by email Literature Review of Precursor Cell Lymphoblastic Leukemia-Lymphoma trials Research Report on Precursor Cell Lymphoblastic Leukemia-Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pyronaridine in Acute Myeloid Leukemia (AML) Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Suspended | Armaceutica, Inc. | 200 | 2028-02-21 | 2026-10-19 |
| Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Blinatumomab, olverembatinib - Phase II Clinical Trial, Blinatumomab | Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 60 | 2027-01-27 | 2026-10-07 |
| Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL Treatment with blinatumomab given subcutaneously. - Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | University of Alberta | 80 | 2027-01-02 | 2026-08-12 |
| CD34+ Transplants for Myeloid Malignancies Busulfan, Melphalan, Fludarabine - Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute | Phase 2 | Not yet recruiting | Guenther Koehne | 50 | 2027-01-01 | 2026-10-13 |
| Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 52 | 2027-01-01 | 2026-09-14 |
| Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies CD7-specific CAR gene-engineered T cells - T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2026-12-31 | 2026-11-02 |
| A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 / Phase 2 | Not yet recruiting | BeOne Medicines | 30 | 2026-12-01 | 2026-10-26 |
| CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II Study MB-CART19.1 - Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Hospital Universitario Dr. Jose E. Gonzalez | 30 | 2026-12-01 | 2026-10-22 |
| Inotuzumab Plus Venetoclax in Older or Unfit Patients With Newly Diagnosed BCR::ABL1-Negative B-ALL Inotuzumab Ozogamicin Plus Venetoclax Induction Therapy - Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) | Phase 2 | Not yet recruiting | Ruijin Hospital | 35 | 2026-11-11 | 2026-11-17 |
| Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | SWOG Cancer Research Network | 90 | 2026-10-14 | 2026-10-13 |
| HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies Capivasertib, Venetoclax, Dexamethasone - Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Phase 1 / Phase 2 | Not yet recruiting | Princess Maxima Center for Pediatric Oncology | 42 | 2026-10-01 | 2025-09-16 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2026-08-28 | 2026-07-30 |
| Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) Asciminib Adult formulation, Asciminib Pediatric formulation, Dexamethasone - Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Phase 1 / Phase 2 | Recruiting | Novartis Pharmaceuticals | 50 | 2026-07-05 | 2026-11-12 |
| A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Autologous nano CD5-CAR T Cells - T-Cell Acute Lymphoblastic Leukemia, T-Lymphoblastic Lymphoma | Phase 1 / Phase 2 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 18 | 2026-06-30 | 2026-07-01 |
| CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia CD22 CAR-transduced T cells, Cyclophosphamide, Fludarabine - Acute Lymphoblastic Leukemia, B-All | Phase 2 | Recruiting | National Cancer Institute (NCI) | 20 | 2026-06-16 | 2026-10-26 |
| SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS SHR2554/AZA + Overlapped mBUCY, mBUCY conditioning Regimen Group - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 180 | 2026-06-01 | 2026-06-10 |
| SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS SHR2554/AZA + Overlapped TBF, mBUCY conditioning regimen - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 160 | 2026-06-01 | 2026-05-01 |
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Collection - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia | Phase 2 | Suspended | University of Washington | 30 | 2026-05-08 | 2026-09-29 |
| Cord Blood Transplantation in Children and Young Adults With Blood Cancer Cord Blood Units, Total Body Irradiation, Cyclophosphamide - Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 71 | 2026-04-28 | 2026-05-14 |
| Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity Tirzepatide, Resistance Exercise, Lifestyle Counseling - Acute Lymphoblastic Leukemia, Obesity | Phase 2 | Recruiting | St. Jude Children's Research Hospital | 20 | 2026-04-23 | 2026-06-04 |
Showing 20 of 984. Sign in to see all of them.
Leukemia, Myeloid, Acute (381) · Leukemia (284) · Lymphoma, Non-Hodgkin (278) · Myelodysplastic Syndromes (256) · Burkitt Lymphoma (247) · Leukemia, Lymphocytic, Chronic, B-Cell (245) · Lymphoma (218) · Hodgkin Disease (198) · Lymphoma, Large B-Cell, Diffuse (195) · Lymphoma, Follicular (190) · Lymphoma, Mantle-Cell (188) · Lymphoma, B-Cell, Marginal Zone (161) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (161) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (157)
Hemic and Lymphatic Diseases (984) · Immunoproliferative Disorders (979) · Neoplasms by Histologic Type (979) · Immune System Diseases (977) · Lymphatic Diseases (975) · Hematologic Diseases (973) · Leukemia, Lymphoid (968) · Lymphoproliferative Disorders (964) · Neoplasms (949) · Leukemia (700) · Pathological Conditions, Signs and Symptoms (479) · Pathologic Processes (473) · Disease Attributes (442) · Leukemia, Myeloid (430) · Chronic Disease (383)
Cyclophosphamide (269) · Methotrexate (155) · Cytarabine (138) · Vincristine (111) · fludarabine phosphate (109) · Dexamethasone (103) · Peripheral Blood Stem Cell Transplantation (93) · Etoposide (87) · Filgrastim (86) · fludarabine (85) · Busulfan (84) · Mycophenolic Acid (83) · Tacrolimus (83) · Whole-Body Irradiation (81) · Rituximab (64)
Fred Hutchinson Cancer Center (69) · M.D. Anderson Cancer Center (63) · National Cancer Institute (NCI) (46) · Masonic Cancer Center, University of Minnesota (27) · St. Jude Children's Research Hospital (24) · Memorial Sloan Kettering Cancer Center (22) · City of Hope Medical Center (21) · Novartis Pharmaceuticals (15) · Children's Oncology Group (14) · Gruppo Italiano Malattie EMatologiche dell'Adulto (13) · Institute of Hematology & Blood Diseases Hospital, China (13) · Case Comprehensive Cancer Center (12) · National Heart, Lung, and Blood Institute (NHLBI) (12) · The First Affiliated Hospital of Soochow University (12) · Roswell Park Cancer Institute (9)
United States (634) · China (94) · Italy (84) · Germany (69) · France (67) · Canada (63) · United Kingdom (45) · Spain (42) · Netherlands (38) · Australia (33) · Belgium (32) · South Korea (24) · Russia (23) · Austria (21) · Japan (20)
Brenda Sandmaier (9) · Elias Jabbour (9) · Ajay Gopal (5) · Elias Jabbour, MD (5) · Ann E. Woolfrey, MD (4) · Brandon Triplett, MD (4) · Marie Bleakley (4) · Partow Kebriaei, MD (4) · Sima Jeha, MD (4) · A. John Barrett, M.D. (3) · Anjali S Advani (3)
PMID 41671463, PMID 35622074, PMID 32499241, PMID 23524640, PMID 34515338, PMID 23065508, PMID 27209293, PMID 33242441, PMID 34048072, PMID 35007144, PMID 19141862, PMID 21527516, PMID 21623761, PMID 22133778, PMID 24862638, PMID 26432046, PMID 28054442, PMID 29358182, PMID 29618479, PMID 32619115, PMID 33496754, PMID 33741715, PMID 34267079, PMID 34353848, PMID 34432863, PMID 35422096, PMID 38551807, PMID 40195173, PMID 41592282, PMID 42154791, PMID 10204198, PMID 11408503, PMID 11675328, PMID 11972517, PMID 12011123, PMID 1403051, PMID 14767498, PMID 14966830, PMID 15107815, PMID 15253677, PMID 15315963, PMID 15817673, PMID 15929131, PMID 16115130, PMID 16155013, PMID 16195338, PMID 16344315, PMID 16564913, PMID 16775235, PMID 16809737
P30CA015704 (31), P01CA018029 (15), P30CA033572 (12), P01CA078902 (10), P30CA043703 (9), U10CA098543 (8), 2023 (7), P30CA015083 (7), U10CA032102 (7), 2018 (6), P30CA008748 (6), U10CA180886 (6), U10CA180888 (6), 2016 (5), 2025 (5)